Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
285 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00884286 | Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma | completed | Phase 2 | 67 | PharmaMarINDUSTRY | 6 | Apr 25, 2018 | clinicaltrials |
| NCT00098839 | Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) | completed | Phase 1 / Phase 2 | 134 | Children's Oncology GroupNETWORK | 4 | Dec 12, 2017 | clinicaltrials |
| NCT00641147 |
| Curcumin in Treating Patients With Familial Adenomatous Polyposis |
| completed |
| Phase 2 |
| 44 |
| National Cancer Institute (NCI)NIH |
| 2 |
| Sep 29, 2017 |
| clinicaltrials |
| NCT00335556 | Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors | completed | Phase 2 | 291 | Children's Oncology GroupNETWORK | 5 | Jul 21, 2017 | clinicaltrials |
| NCT00856492 | S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer | completed | Phase 2 | 215 | SWOG Cancer Research NetworkNETWORK | 2 | Jun 27, 2017 | clinicaltrials |
| NCT01440374 | A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia(ASPIRE) | completed | Phase 2 | 162 | Novartis PharmaceuticalsINDUSTRY | 22 | Jun 5, 2017 | clinicaltrials |
| NCT00153816 | Vitamin D/Calcium Polyp Prevention Study | completed | Phase 2 / Phase 3 | 2,813 | Dartmouth-Hitchcock Medical CenterOTHER | 2 | Mar 15, 2017 | clinicaltrials |
| NCT00873093 | Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | completed | Phase 2 | 148 | National Cancer Institute (NCI)NIH | 4 | Jan 27, 2017 | clinicaltrials |
| NCT00041054 | Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 41 | Alliance for Clinical Trials in OncologyOTHER | 3 | Dec 7, 2016 | clinicaltrials |
| NCT01087151 | A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL) | completed | Phase 2 | 118 | Genentech, Inc.INDUSTRY | 12 | Nov 2, 2016 | clinicaltrials |
| NCT00064272 | UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer(IRB 2003-551) | completed | Phase 2 | 180 | University of Michigan Rogel Cancer CenterOTHER | 2 | Oct 21, 2016 | clinicaltrials |
| NCT00312286 | Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women. | terminated | Phase 2 | 538 | TakedaINDUSTRY | 3 | Sep 23, 2016 | clinicaltrials |
| NCT01022346 | A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection | completed | Phase 2 | 206 | Hoffmann-La RocheINDUSTRY | 6 | Aug 15, 2016 | clinicaltrials |
| NCT00020943 | Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma | completed | Phase 2 | 79 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 19, 2016 | clinicaltrials |
| NCT00032019 | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | completed | Phase 2 | 78 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 19, 2016 | clinicaltrials |
| NCT00002624 | Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function | completed | Phase 2 | 66 | Alliance for Clinical Trials in OncologyOTHER | 4 | Jul 14, 2016 | clinicaltrials |
| NCT00003565 | Docetaxel in Treating Patients With Solid Tumors | completed | Phase 2 | 109 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 14, 2016 | clinicaltrials |
| NCT00006029 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 91 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00006125 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma | completed | Phase 2 | — | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00006265 | Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | completed | Phase 2 | 60 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00012220 | Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas | completed | Phase 2 | 259 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00023751 | Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer | completed | Phase 2 | 320 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 6, 2016 | clinicaltrials |
| NCT00005850 | Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 21 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 4, 2016 | clinicaltrials |
| NCT00052845 | Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 80 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 1, 2016 | clinicaltrials |
| NCT01599949 | A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy | completed | Phase 2 | 120 | Janssen Research & Development, LLCINDUSTRY | 9 | Jun 1, 2016 | clinicaltrials |
| NCT00698841 | Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors | completed | Phase 2 | 79 | Eli Lilly and CompanyINDUSTRY | 2 | Dec 24, 2015 | clinicaltrials |
| NCT01109524 | Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 72 | Eli Lilly and CompanyINDUSTRY | 3 | Dec 24, 2015 | clinicaltrials |
| NCT00890305 | Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone | completed | Phase 2 | 171 | Medivation, Inc.INDUSTRY | 6 | Jul 8, 2015 | clinicaltrials |
| NCT00066365 | Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma | completed | Phase 2 | 49 | Children's Oncology GroupNETWORK | 4 | Mar 30, 2015 | clinicaltrials |
| NCT00470275 | Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma | completed | Phase 2 | 10 | Children's Oncology GroupNETWORK | 4 | Oct 20, 2014 | clinicaltrials |
| NCT00021242 | Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia | completed | Phase 2 | 12 | Children's Oncology GroupNETWORK | 7 | Aug 8, 2014 | clinicaltrials |
| NCT00002941 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma | completed | Phase 2 | 69 | Children's Oncology GroupNETWORK | 7 | Aug 1, 2014 | clinicaltrials |
| NCT00003234 | Vinorelbine in Treating Children With Recurrent or Refractory Cancers | completed | Phase 2 | 50 | Children's Oncology GroupNETWORK | 7 | Jul 28, 2014 | clinicaltrials |
| NCT00003783 | Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia | completed | Phase 2 | 36 | Children's Oncology GroupNETWORK | 5 | Jul 28, 2014 | clinicaltrials |
| NCT00002804 | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 43 | Children's Oncology GroupNETWORK | 3 | Jul 25, 2014 | clinicaltrials |
| NCT00003178 | Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia | completed | Phase 2 | 120 | Children's Oncology GroupNETWORK | 7 | Jul 25, 2014 | clinicaltrials |
| NCT00003573 | Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma | completed | Phase 2 | 53 | Children's Oncology GroupNETWORK | 5 | Jul 25, 2014 | clinicaltrials |
| NCT00003671 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia | completed | Phase 2 | 59 | Children's Oncology GroupNETWORK | 5 | Jul 25, 2014 | clinicaltrials |
| NCT00429702 | Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy | terminated | Phase 2 | 7 | University of South FloridaOTHER | 2 | Jul 25, 2014 | clinicaltrials |
| NCT00002594 | Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors | completed | Phase 2 | 31 | Children's Oncology GroupNETWORK | 6 | Jul 24, 2014 | clinicaltrials |
| NCT00002621 | Interferon Alfa in Treating Children With HIV-Related Cancer | completed | Phase 2 | 8 | Children's Oncology GroupNETWORK | 4 | Jul 24, 2014 | clinicaltrials |
| NCT01447927 | Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus | completed | Phase 2 | 93 | National Cancer Institute (NCI)NIH | 3 | Jul 21, 2014 | clinicaltrials |
| NCT00236041 | Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP) | completed | Phase 2 | 38 | CephalonINDUSTRY | 2 | May 9, 2014 | clinicaltrials |
| NCT00236093 | Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain | completed | Phase 2 | — | CephalonINDUSTRY | 3 | May 9, 2014 | clinicaltrials |
| NCT00028795 | Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma | completed | Phase 2 | 170 | Children's Oncology GroupNETWORK | 7 | Feb 21, 2014 | clinicaltrials |
| NCT00006462 | Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia | completed | Phase 2 | 32 | Children's Oncology GroupNETWORK | 7 | Feb 20, 2014 | clinicaltrials |
| NCT00070174 | Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy | completed | Phase 2 | 350 | Children's Oncology GroupNETWORK | 5 | Feb 20, 2014 | clinicaltrials |
| NCT00003955 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma | completed | Phase 2 | 77 | Children's Oncology GroupNETWORK | 7 | Feb 14, 2014 | clinicaltrials |
| NCT00098683 | Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes | completed | Phase 2 | 10 | Children's Oncology GroupNETWORK | 4 | Feb 13, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials